Corrigendum: Metabolic Profiling of a CB2 Agonist, AM9338, Using LC-MS and Microcoil-NMR: Identification of a Novel Dihydroxy Adamantyl Metabolite

[This corrects the article DOI: 10.3389/fphar.2020.575691.].

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Frontiers in pharmacology Jg. 12; S. 630274
Hauptverfasser: Honrao, Chandrashekhar, Ma, Xiaoyu, Kulkarni, Shashank, Joshi, Vinit, Malamas, Michael, Zvonok, Alexander, Wood, JodiAnne, Kautz, Roger A., Strand, David, Guo, Jason J., Makriyannis, Alexandros
Format: Journal Article
Sprache:Englisch
Veröffentlicht: Switzerland Frontiers Media S.A 22.04.2021
Schlagworte:
Adamantyl metabolism
CYP3A4 metabolism
di-hydroxyl adamantyl metabolite
LC-MS
metabolite identification
micro-coil NMR
Pharmacology
CYP3A4 metabolism
LC-MS
CB2 agonist
di-hydroxyl adamantyl metabolite
micro-coil NMR
Adamantyl metabolism
metabolite identification
cannabinoid metabolism
ISSN:1663-9812, 1663-9812
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:[This corrects the article DOI: 10.3389/fphar.2020.575691.].
Bibliographie:corrigendum
ObjectType-Correction/Retraction-1
content type line 23
SourceType-Scholarly Journals-1
Deceased.
Approved by: Frontiers in Pharmacology Editorial Office, Frontiers Media SA, Switzerland
This article was submitted to Drug Metabolism and Transport, a section of the journal Frontiers in Pharmacology
ISSN:1663-9812
1663-9812
DOI:10.3389/fphar.2021.630274